McDonnell: Out Shopping For Neuroscience Bargains

During the past several years, the James S. McDormell Foundation’s support of scientific research has grown significantly—and so has its determination to spend its grant money where it will create the greatest possible impact on scientific research. The foundation’s recent thrust into the realm of cognitive neuroscience dramatically shows the new attitude that, if it’s going to be a bigger spender, it must also be, so to speak, a better shopper. Launched in 1950 on t

Written byJohn Rubin
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

During the past several years, the James S. McDormell Foundation’s support of scientific research has grown significantly—and so has its determination to spend its grant money where it will create the greatest possible impact on scientific research. The foundation’s recent thrust into the realm of cognitive neuroscience dramatically shows the new attitude that, if it’s going to be a bigger spender, it must also be, so to speak, a better shopper.

Launched in 1950 on the strength of a $500,000 gift from aerospace industry magnate James McDonnell, the St. Louis-based organization maintained for the first three decades of its existence the low-proffle image of a moderately endowed hometown angel, specializing in good-neighbor donations to schools, hospitals, and charities in its headquarters city.

In its early years, the foundation’s total giving made only small ripples in the nation’s overall philanthropic pool. In 1969, for example, the 26 grants it awarded totaled ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies